Terumo Corp,

Terumo Corporation is a premier global medical device manufacturer with a history spanning over a century. It was established in 1921 by a group of scientists, including the renowned Dr. Shibasaburo Kitasato, known as the "father of modern medicine in Japan." The company's origin lies in the domestic production of high-quality thermometers, which were in short supply during World War I. Since then, Terumo has evolved in tandem with the advancement of healthcare, consistently supporting the foundations of medical practice in Japan and across the globe.

Guided by its corporate mission, "Contributing to Society through Healthcare," Terumo currently provides an extensive range of products and services in more than 160 countries and regions. As a truly global enterprise, approximately 70% of its revenue is generated outside of Japan. The business is organized into three main companies:

First is the Cardiac and Vascular Company. This division provides essential products for cardiac and vascular surgery, as well as interventional treatments. Terumo is a global leader in minimally invasive treatments, particularly in promoting "Transradial Intervention (TRI)," a procedure where catheters are inserted through the wrist. This technique significantly reduces physical stress on patients and shortens recovery times, demonstrating Terumo’s commitment to patient-centric innovation.

Second is the Medical Care Solutions Company. Building on its heritage of thermometers and blood pressure monitors, this company offers infusion systems, peritoneal dialysis, and pre-filled syringes developed in partnership with pharmaceutical companies. Its goal is to provide comprehensive solutions that address challenges in medical settings, such as preventing medical errors, controlling hospital-acquired infections, and improving the efficiency of nursing care.

Third is the Blood and Cell Technologies Company. This division supports transfusion medicine through blood bags and automated blood component collection systems. Furthermore, it provides manufacturing platforms for cutting-edge fields like cell and gene therapy, which are shaping the future of medicine.

Terumo’s core strengths lie in its sophisticated manufacturing technologies and its commitment to "Genba" (on-site) product development that transforms medical needs into reality. The company also operates "Terumo Medical Pranex," a state-of-the-art training facility for healthcare professionals to refine their clinical skills, illustrating a dedication that goes beyond just selling products. Moving forward, Terumo aims to realize sustainable healthcare by providing value-based solutions, continuing its growth as a trusted partner for medical professionals and patients worldwide.